Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serotonin Transporter Binding in Tourette Syndrome and Obsessive-Compulsive Disorder Treated With Escitalopram
2005-001411-22Phase 3Terminated
- Sponsor
- Hannover Medical School
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of escitalopram in obsessive compulsive disorder (OCD) and Tourette syndrome (TS) (2 arms), sponsored by Hannover Medical School. Started Oct 2005; status: terminated.
02
Drugs
escitalopram
03
Conditions
obsessive compulsive disorder (OCD)Tourette syndrome (TS)
Beyond the preview
Go deeper on 2005-001411-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001411-22.